Reduced Anticoagulation Targets in ECLS (RATE)

NCT04536272 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Respiratory Failure
Extracorporeal Membrane Oxygenation
Bleeding
Thrombosis

Interventions

DRUG: Heparin
DRUG: LMWH

Sponsor

University Medical Center Groningen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]